Asset Management One’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
Asset Management One's NVCR Position: Q4 2023 in Review
Asset Management One sold out of NovoCure (NVCR) in Q4 2023, closing a stake of 19,325 shares — an estimated $312K sold.
Asset Management One first reported a position in NVCR in Q4 2019 and held it in 16 quarters. The position peaked at $11.8M in Q2 2021. 219 funds tracked by Wall St. Rank hold NVCR as of Q4 2023.
- Asset Management One reported no remaining NovoCure position as of Q4 2023 after selling out during the quarter.
- Asset Management One sold 19,325 NovoCure shares in Q4 2023, an estimated $312K.
- Asset Management One first reported a position in NovoCure in Q4 2019 and held it in 16 quarters.
- Asset Management One's NovoCure position peaked at $11.8M in Q2 2021.
- 219 funds tracked by Wall St. Rank held NovoCure as of Q4 2023.
Based on Asset Management One's 13F filing for Q4 2023, filed 24 Jan 2024.